Target
Mitogen-activated protein kinase kinase kinase 14
Ligand
BDBM50266976
Substrate
n/a
Meas. Tech.
ChEMBL_1701709 (CHEMBL4052942)
Ki
2.9±n/a nM
Citation
 Castanedo, GMBlaquiere, NBeresini, MBravo, BBrightbill, HChen, JCui, HFEigenbrot, CEverett, CFeng, JGodemann, RGogol, EHymowitz, SJohnson, AKayagaki, NKohli, PBKnüppel, KKraemer, JKrüger, SLoke, PMcEwan, PMontalbetti, CRoberts, DASmith, MSteinbacher, SSujatha-Bhaskar, STakahashi, RWang, XWu, LCZhang, YStaben, ST Structure-Based Design of Tricyclic NF-?B Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K). J Med Chem 60:627-640 (2017) [PubMed]  Article 
Target
Name:
Mitogen-activated protein kinase kinase kinase 14
Synonyms:
HsNIK | M3K14_HUMAN | MAP3K14 | NF-kappa-beta-inducing kinase | NF-kappa-beta-inducing kinase (NF-kB) | NIK | Serine/threonine-protein kinase NIK
Type:
Protein
Mol. Mass.:
104059.50
Organism:
Homo sapiens (Human)
Description:
Q99558
Residue:
947
Sequence:
MAVMEMACPGAPGSAVGQQKELPKAKEKTPPLGKKQSSVYKLEAVEKSPVFCGKWEILNDVITKGTAKEGSEAGPAAISIIAQAECENSQEFSPTFSERIFIAGSKQYSQSESLDQIPNNVAHATEGKMARVCWKGKRRSKARKKRKKKSSKSLAHAGVALAKPLPRTPEQESCTIPVQEDESPLGAPYVRNTPQFTKPLKEPGLGQLCFKQLGEGLRPALPRSELHKLISPLQCLNHVWKLHHPQDGGPLPLPTHPFPYSRLPHPFPFHPLQPWKPHPLESFLGKLACVDSQKPLPDPHLSKLACVDSPKPLPGPHLEPSCLSRGAHEKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQANYHQTLHAQPRELSPRAPGPRPAEETTGRAPKLQPPLPPEPPEPNKSPPLTLSKEESGMWEPLPLSSLEPAPARNPSSPERKATVPEQELQQLEIELFLNSLSQPFSLEEQEQILSCLSIDSLSLSDDSEKNPSKASQSSRDTLSSGVHSWSSQAEARSSSWNMVLARGRPTDTPSYFNGVKVQIQSLNGEHLHIREFHRVKVGDIATGISSQIPAAAFSLVTKDGQPVRYDMEVPDSGIDLQCTLAPDGSFAWSWRVKHGQLENRP
  
Inhibitor
Name:
BDBM50266976
Synonyms:
CHEMBL4065087
Type:
Small organic molecule
Emp. Form.:
C19H18FN3O2
Mol. Mass.:
339.3635
SMILES:
CC(C)(O)C#Cc1cc2-c3nc(cn3C3CC(C3)c2cc1F)C(N)=O |(21.05,-18.64,;21.82,-19.96,;22.58,-18.63,;23.14,-20.72,;20.49,-20.74,;19.14,-21.51,;17.81,-22.28,;16.48,-21.51,;15.14,-22.28,;13.93,-21.32,;14.07,-19.79,;12.65,-19.17,;11.65,-20.33,;12.42,-21.67,;11.76,-23.06,;12.43,-24.44,;13.93,-24.79,;13.28,-23.05,;15.14,-23.82,;16.48,-24.59,;17.81,-23.82,;19.13,-24.59,;12.33,-17.7,;10.82,-17.27,;13.42,-16.6,)|
Structure:
Search PDB for entries with ligand similarity: